TA-993

N/A

Report date: 2022/03/14 18:05:38
NME

Base Information

Drug NameTA-993
Drug Alias NameTA-993
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockersPlatelet aggregation inhibitorsPlatelet-activating factor inhibitors
TargetsVoltage-gated calcium channelPlatelet-activating factor
Therapy Area/IndicationsArterial Occlusive Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMitsubishi Tanabe Pharma
Active IndicationsN/A
Inactive IndicationsArterial Occlusive Diseases

Other Information

ATC CodeN/A
Related LinksN/A